This website uses cookies and other technologies to personalize content and ads on this and other websites and provide social media features. By clicking "I Agree" you consent to our use of tracking technologies and disclosure of tracking data to third party ad networks or social media companies for the purposes above. If you click "I Disagree" you can still use this website. For more information about Lilly’s privacy practice and to manage third-party preferences, click here.

EMGALITY HOME

FOR CONSUMERS

EPISODIC CLUSTER HEADACHE HOME

People with 15+ headache days per month did not achieve significant differences on the impact of daily activities vs placebo

1 migraine day per week is 52 migraine days per year

What is your migraine impact number?

Migraine is more than a headache, it's a debilitating disease that impacts over 30 million adults in the United States. Take this quiz to find out just how much migraine impacts your life, and share with others who have migraine.

Provide your information and you will receive an email with your results so you can start the conversation with your doctor.

This is not a validated scale and is not intended for use in the diagnosis of migraine or treatment recommendation.

Emgality is a prescription medicine used for the preventive treatment of migraine in adults.

Select Safety Information
Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.

Purpose & Safety Summary
PURPOSE and SAFETY SUMMARY

Important Facts About Emgality® (em-GAL-it-ē) injection. Also known as galcanezumab-gnlm.

Emgality is a prescription medicine used in adults for:

  • The preventive treatment of migraine. The medicine (120 mg) comes in a prefilled pen or syringe and is taken once a month.
  • The treatment of episodic cluster headache. The medicine (300 mg) comes in three (100 mg) prefilled syringes, which are taken one after the other at the start of a cluster period and then every month until the end of the cluster period.

Warnings
Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.

Emgality may cause allergic reactions, such as itching, rash, hives, and trouble breathing. Allergic reactions can happen days after using Emgality. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, which may be part of an allergic reaction: swelling of your face, mouth, tongue, or throat, or trouble breathing.
Common side effects
The most common side effects of Emgality are injection site reactions.
These are not all the possible side effects of Emgality. Tell your doctor if you have any side effects.
You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.
Before using
Before you use Emgality, discuss these questions with your doctor:
❑ Do you have other medical conditions?
❑ Do you take other medicines? Tell your doctor about all the prescription and over-the-counter drugs, vitamins, and herbal supplements you take.

Tell your doctor if:
❑ You are pregnant or breastfeeding.
❑ You are under age 18. It is not known if Emgality is safe and effective in children.
How to take
  • Read the Instructions for Use that come with Emgality. There you will find information about how to store, prepare, and inject Emgality.
  • Use Emgality exactly as your doctor says.
  • If you miss a dose, inject it as soon as possible. Then do the following:
    • For migraine: Continue to take Emgality monthly from the date of your last dose.
    • For episodic cluster headache: If your cluster period has not ended, inject Emgality one month after your last dose to get back on a monthly dosing schedule.
Learn more
For more information, call 1-833-EMGALITY (1-833-364-2548).

This summary provides basic information about Emgality, but it does not include all information known about this medicine. Read the information that comes with your prescription every time you have a prescription filled. Talk to your doctor or pharmacist about this information. Your doctor is the best person to help you decide if Emgality is right for you.
Emgality® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. ©Lilly USA, LLC 2021. All rights reserved.
GZ CON COMBO BS 04JUN2019
Please see Full Prescribing Information, including Patient Information, for Emgality. See Instructions for Use included with the device.

Are you a US healthcare provider?

The information contained in this section of Emgality.com is intended for US healthcare providers. Please confirm below.

Are you a US healthcare provider?

The information contained in this section of Emgality.com is intended for US healthcare providers. Please confirm below.

You are now leaving Emgality.com.

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click “Continue” to leave site or “Return to Emgality.com” to close this window and return to Emgality.com.

You are now leaving Emgality.com.

The link you clicked on will take you to a site maintained by a third party. Eli Lilly and Company, the manufacturer of Emgality, has contracted with Cove for certain services including but not limited to Lilly sponsored messages, and content on the site you are going to. Lilly does not otherwise control or influence any content, functionality, opinions, claims or comments expressed on the site, including any physician consultation, medical advice (which may include any medication in the event of a product prescription), or otherwise, all of which is the sole responsibility of the site owner. Lilly USA, LLC is not responsible for the privacy policy or terms and conditions of this or any third-party websites. We encourage you to read the privacy policy and terms of conditions of every website you visit.

By clicking “Continue” you agree to these terms and will be directed to the third party site, OR, click on “Return to Emgality.com” to close this window and return to Emgality.com.